By these immunohistochemical assays, we could not find a statistically significant difference between patients with high vs low ALK antibodies titers for the amount of T cell infiltrates or the expression of PD-L1 by the tumor cells (Supplementary Figure 5A-5B). The gene discussed is ALK; the disease is neoplasm.